» Articles » PMID: 11385576

Association of NOD2 Leucine-rich Repeat Variants with Susceptibility to Crohn's Disease

Overview
Journal Nature
Specialty Science
Date 2001 Jun 1
PMID 11385576
Citations 1733
Authors
Affiliations
Soon will be listed here.
Abstract

Crohn's disease and ulcerative colitis, the two main types of chronic inflammatory bowel disease, are multifactorial conditions of unknown aetiology. A susceptibility locus for Crohn's disease has been mapped to chromosome 16. Here we have used a positional-cloning strategy, based on linkage analysis followed by linkage disequilibrium mapping, to identify three independent associations for Crohn's disease: a frameshift variant and two missense variants of NOD2, encoding a member of the Apaf-1/Ced-4 superfamily of apoptosis regulators that is expressed in monocytes. These NOD2 variants alter the structure of either the leucine-rich repeat domain of the protein or the adjacent region. NOD2 activates nuclear factor NF-kB; this activating function is regulated by the carboxy-terminal leucine-rich repeat domain, which has an inhibitory role and also acts as an intracellular receptor for components of microbial pathogens. These observations suggest that the NOD2 gene product confers susceptibility to Crohn's disease by altering the recognition of these components and/or by over-activating NF-kB in monocytes, thus documenting a molecular model for the pathogenic mechanism of Crohn's disease that can now be further investigated.

Citing Articles

Crohn's Disease-associated variant in laccase domain containing 1 (LACC1) modulates T cell gene expression, metabolism and T cell function.

Li Y, Ascui G, Dicker M, Riffelmacher T, Chandra V, Schmiedel B Nat Commun. 2025; 16(1):2577.

PMID: 40089498 DOI: 10.1038/s41467-025-57744-3.


High-Throughput Whole-Exome Sequencing and Large-Scale Computational Analysis to Identify the Genetic Biomarkers to Predict the Vedolizumab Response Status in Inflammatory Bowel Disease Patients from Saudi Arabia.

Aljohani H, Anbarserry D, Mosli M, Ujaimi A, Bakhshwin D, Elango R Biomedicines. 2025; 13(2).

PMID: 40002872 PMC: 11852680. DOI: 10.3390/biomedicines13020459.


Risk factors for inflammatory bowel disease: an umbrella review.

Wu T, Cheng H, Zhuang J, Liu X, Ouyang Z, Qian R Front Cell Infect Microbiol. 2025; 14:1410506.

PMID: 39926114 PMC: 11802543. DOI: 10.3389/fcimb.2024.1410506.


Unraveling the role of autophagy regulation in Crohn's disease: from genetic mechanisms to potential therapeutics.

Yuan Z, Ye J, Liu B, Zhang L Adv Biotechnol (Singap). 2025; 2(2):14.

PMID: 39883213 PMC: 11740883. DOI: 10.1007/s44307-024-00021-z.


[Update on the pathophysiology, prediction and prevention of inflammatory bowel diseases].

Fischer S, Neurath M Inn Med (Heidelb). 2025; 66(2):137-145.

PMID: 39833377 DOI: 10.1007/s00108-024-01838-5.